Concepedia

S. Pazhanisamy

SP

19

Publications

1.2K

Citations

15

H-Index

1984

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Wesleyan University

S. Pazhanisamy is an author at Vertex Pharmaceuticals (United States) specializing in biochemistry, medicine, and drug discovery.

Top concepts

Publications per year

1984–2011

19

Publications

19

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

Keith P. Wilson, Patricia G. McCaffrey, Kathy Hsiao et al. · Chemistry & Biology · 1997 · 275 citations · Full text

, , +10

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease

Judith A. Partaledis, Koushi Yamaguchi, Margaret Tisdale et al. · Journal of Virology · 1995 · 186 citations · Full text

A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase

Ted Fox, Joyce T. Coll, Xiaoling Xie et al. · Protein Science · 1998 · 135 citations · Full text

In Vitro and In Vivo Isotope Effects with Hepatitis C Protease Inhibitors: Enhanced Plasma Exposure of Deuterated Telaprevir versus Telaprevir in Rats

François Maltais, Young Chun Jung, Minzhang Chen et al. · Journal of Medicinal Chemistry · 2009 · 97 citations

The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor

John P. Duffy, Edmund Harrington, Francesco G. Salituro et al. · ACS Medicinal Chemistry Letters · 2011 · 82 citations · Full text

Rows per page

1–5 of 19